Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 6/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.37 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.37 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.34 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | AURKA | O14965 | 1/20 | 0.33 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.33 |
| ▸ | KDM1A | O60341 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16249981 | 0.88 | HDAC3 (0.40) | HDAC3HDAC1HDAC2HDAC10HDAC8 | |
| Hydrochloric Acid SCHEMBL16754672 | 0.88 | HDAC3 (0.40) | HDAC3HDAC1HDAC2HDAC10HDAC8 | |
| SCHEMBL19365383 | 0.87 | CA1 (0.37) | NOTUMCA12CA1CA2CA9 | |
| SCHEMBL16238397 | 0.80 | AURKA (0.37) | HDAC3HDAC1HDAC2HDAC10HDAC8 | |
| SCHEMBL19706003 | 0.79 | HDAC3 (0.40) | HDAC3HDAC1HDAC2HDAC10HDAC8 | |
| SCHEMBL16238490 | 0.78 | AURKA (0.40) | HDAC3HDAC1HDAC2HDAC10HDAC8 | |
| SCHEMBL19670361 | 0.77 | HDAC3 (0.40) | HDAC3HDAC1HDAC2HDAC10HDAC8 | |
| SCHEMBL16238555 | 0.77 | NOTUM (0.46) | HDAC3HDAC1HDAC2HDAC10HDAC8 | |
| SCHEMBL19365864 | 0.76 | KMT2A (0.39) | HDAC3HDAC1HDAC2HDAC10HDAC8 | |
| SCHEMBL17624649 | 0.76 | CA12 (0.49) | CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180044338-A1 | SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS | GLAXOSMITHKLINE LLC (US) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180044338-A1 | SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS | SIRT1, SIRT3, SIRT2 | HDAC3 86/4885HDAC1 64/4885HDAC2 72/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.